Nobac Plus Ab-f E2
NDC Package 31511-009-02
Package Information
Nobac Plus Ab-f E2 is a . Marketed by Mason Chemical Company, this product is identified by NDC 31511-009 and is authorized under FDA application part333A.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 31511 - Mason Chemical Company
- 31511-009 - Nobac Plus Ab-f E2
- 31511-009-02 - 210 mL in 1 BOTTLE, PLASTIC
- 31511-009 - Nobac Plus Ab-f E2
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 31511-009-02 identifies a specific commercial package of 210 ml in 1 bottle, plastic of Nobac Plus Ab-f E2, labeled by Mason Chemical Company. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Mason Chemical Company on February 10, 2012. The current certification is valid through January 30, 2020.
How is this Mason Chemical Company product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 31511000902. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.